Q32 Bio (QTTB) Non Operating Income (2017 - 2026)

Q32 Bio (QTTB) recorded quarterly Non Operating Income of $113000.0 in Q1 2026, down 0.88% quarter-over-quarter from $114000.0 in Q4 2025, and down 90.56% on a YoY basis from $1.2 million in Q1 2025.

Q32 Bio (QTTB) Non Operating Income (2017 - 2026) Analysis & Trends

Q32 Bio's Non Operating Income history runs 10 years deep, the most recent figure standing at $113000.0 for Q1 2026.

  • In Q1 2026, Non Operating Income fell 90.56% year-over-year to $113000.0; the TTM figure through Mar 2026 stood at $97000.0 (down 98.12% YoY), while the FY2025 annual figure was $1.2 million, down 94.09% from the prior year.
  • Non Operating Income was $113000.0 for Q1 2026 at Q32 Bio, down from $114000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $131.3 million in Q1 2022 to a low of -$6.2 million in Q3 2023.
  • Historically, Non Operating Income has averaged $8.6 million across 5 years, with a median of $578000.0 in 2023.
  • The sharpest annual moves came in 2022 and 2023: Non Operating Income jumped 345376.32% in 2022, then slumped 586.05% in 2023.
  • A 5-year view of Non Operating Income shows it stood at $1.5 million in 2022, then plunged by 512.16% to -$6.0 million in 2023, then soared by 105.97% to $358000.0 in 2024, then slumped by 68.16% to $114000.0 in 2025, then fell by 0.88% to $113000.0 in 2026.
  • The last three Non Operating Income figures came in at $113000.0 (Q1 2026), $114000.0 (Q4 2025), and $188000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Q32 Bio 167.59 Mn 116.84 Mn - 113,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 113,000.00
Dec 31, 2025 114,000.00
Sep 30, 2025 188,000.00
Jun 30, 2025 -318,000.00
Mar 31, 2025 1.20 Mn
Dec 31, 2024 358,000.00
Sep 30, 2024 1.22 Mn
Jun 30, 2024 2.39 Mn
Mar 31, 2024 16.05 Mn
Dec 31, 2023 -6.00 Mn
Sep 30, 2023 -6.17 Mn
Jun 30, 2023 1.47 Mn
Mar 31, 2023 578,000.00
Dec 31, 2022 1.46 Mn
Sep 30, 2022 1.27 Mn
Jun 30, 2022 474,000.00
Mar 31, 2022 131.28 Mn
Dec 31, 2021 42,000.00
Sep 30, 2021 53,000.00
Jun 30, 2021 52,000.00